A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for the coronavirus, Monday, March 16, at the Kaiser Permanente Washington Health Research Institute in Seattle. A syringe containing the first shot given in the first-stage safety study clinical trial of a potential vaccine for the new coronavirus, rests on a table, Monday, March 16, at the Kaiser Permanente Washington Health Institute. Previous NextU.S. researchers gave the first shots in a first test of an experimental coronavirus vaccine Monday, leading off a worldwide hunt for protection even as the pandemic that spread from China, surges. With careful jabs in the arms of four healthy volunteers, scientists at the Kaiser Permanente Washington Research Institute in Seattle began an anxiously awaited first-stage study of a potential vaccine developed in record time after the new virus exploded out of China and fanned out across the globe. “We’re team coronavirus now,” Kaiser Permanente study leader Dr. Lisa Jackson said on the eve of the experiment.

Source: The Standard March 17, 2020 10:52 UTC